Comprehensive Immuno-Oncology Testing

Explore More CDx Options with All Currently Available
PD-L1 IVDs, Tumor Mutation Burden, MSI, and MMR

Learn More

PD-L1 Testing in Solid Tumors

WEBINAR

July 27, 2017 | 2 PM to 3 PM ET

Join Dr. Goldstein for a comprehensive overview
of PD-L1 testing, PD1 therapy, and recent
updates regarding dMMR/MSI-high cancers.

REGISTER NOW

Online%20test%20Ordering

What are the top five ways

Online Test Ordering

can improve your day and your workflow?

Answers Here

Universal-Fusion%2FExpression%20Profile

The Universal Fusion/Expression Profile

Expanding the Boundaries of Cancer Diagnostics

Introducing

NeoLab-Prostate-Biopsy-free

No pain. All the gain.

Biopsy-free NeoLAB™ Prostate

An innovative, non-invasive liquid biopsy
test that uses biomarkers in blood and urine,
to assess prostate cancer risk

Learn more

Pharma Services

Pharma Services

NeoGenomics offers lab services for oncology clinical trials

Learn more 

NeoGenomics Industy Events

Upcoming Events

Meet with NeoGenomics at an upcoming tradeshow

Click here to view

HER-2%20Breast%20FISH

NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017

Read press release

KRAS%20BRAF%20EGFR%20Mutation

New Article in Springer Nature

Detecting BRAF, KRAS, and EGFR Mutations via NGS vs. PCR-based Kits

Read now

HER-2%20Breast%20FISH

HER-2 Breast FISH Alternative Assessment

The 2017 July-December self-assessment for our tech-only FISH clients is ready.

Sign into NeoUniversity™

HER-2%20Breast%20FISH

NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests

Read press release

HER-2%20Breast%20FISH

NeoGenomics Reports that its NeoLAB® Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer

Read press release

Combined Urine and Plasma Biomarkers are Highly Accurate for Predicting High Grade Prostate Cancer

View poster

View presentation

HER-2%20Breast%20FISH

Now Available: New Posters from AACR

MultiOmyx™ integrated analysis with NanoString; Upregulating PD-L1 in lung cancer.

Learn more

Universal%20Fusion

NeoTYPE® GI Predictive Profile

RAS/RAF, MSI, HER2, and PD-L1 to maximize options for therapy in GI cancers

Learn more

Universal%20Fusion

Tumor Mutation Burden

Now available with NeoTYPE™ Solid Tumor Profiles and as stand-alone test

Learn more

Universal%20Fusion

All PD-L1 IHC IVD Assays Available

NeoGenomics leads the way in Immuno-Oncology with SP263 (NEW!), 28-8, 22C3, SP142

Learn more

HPV%20RNA%20ISHPanel

The HPV RNA ISH Panel detects E6/E7 mRNA in 28 HPV subtypes. This test replaces the DNA ISH Panel effective February 27, 2017.

Learn more

HPV RNA ISH Panel

NeoLab%20EGFR

NeoLABTM EGFR T790M Liquid Biopsy

Learn more

Accurate and sensitive detection of the EGFR T790M mutation using cell-free plasma DNA

Universal%20Fusion

Universal Fusion/Expression Profile

Broad detection of fusion transcripts and gene expression in 1385 cancer genes

Learn more